{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T20:20:01Z","timestamp":1769631601799,"version":"3.49.0"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,1]]},"abstract":"<jats:p>OBJECTIVE. Mild hypothermia for 72 hours is neuroprotective in newborns with moderate or severe hypoxic-ischemic encephalopathy. A core temperature of 33.5\u00b0C might reduce drug clearance leading to potential toxicity. Gentamicin is nephrotoxic and ototoxic at high serum concentrations. No study has investigated the influence of 72 hours of hypothermia on serum gentamicin concentrations (SGCs) in children of any age. We aimed to compare the SGCs in encephalopathic infants who underwent intensive care with therapeutic hypothermia or normothermia.<\/jats:p>\n               <jats:p>METHODS. Data were collected retrospectively from 2 NICUs in Bristol, United Kingdom, that offered cooling therapy within clinical trials since 1998. Eligible infants (n = 55) developed grade 2\/3 encephalopathy after birth and fulfilled the entry criteria defined in the CoolCap trial. Encephalopathic infants with similar demographic values were either nursed under normothermia or 72 h-hypothermia. Once-daily gentamicin dosage (4\u20135 mg\/kg) was administered, and trough SGC was recorded with corresponding creatinine concentrations. The time and number of omitted drug doses were noted.<\/jats:p>\n               <jats:p>RESULTS. Mean trough SGC (pre\u2013second dose) and mean plasma creatinine concentrations for both treatment groups were similar (gentamicin: 2.19 \u00b1 1.7 [hypothermia] and 2.30 \u00b1 2.0 [normothermia] mg\/L; creatinine: 115.6 \u00b1 42.8 [hypothermia] and 121.0 \u00b1 45.1 [normothermia] \u03bcmol\/L). Forty percent of the trough SGCs in both groups were above the recommended trough concentration of 2.0 mg\/L. A significant correlation (r2 = 0.36) was found between high SGCs and impaired renal function assessed by raised plasma creatinine levels regardless of treatment options.<\/jats:p>\n               <jats:p>CONCLUSIONS. Our data confirm that impaired renal function is strongly associated with high SGCs. Reduced body temperatures do not affect the clearance of gentamicin.<\/jats:p>","DOI":"10.1542\/peds.2008-2942","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T15:18:44Z","timestamp":1246288724000},"page":"310-315","source":"Crossref","is-referenced-by-count":56,"title":["Serum Gentamicin Concentrations in Encephalopathic Infants are Not Affected by Therapeutic Hypothermia"],"prefix":"10.1542","volume":"124","author":[{"given":"Xun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Child Health, St Michael's Hospital, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manobi","family":"Borooah","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, Southmead Hospital, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Bristol Royal Infirmary, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ela","family":"Chakkarapani","sequence":"additional","affiliation":[{"name":"Department of Child Health, St Michael's Hospital, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Thoresen","sequence":"additional","affiliation":[{"name":"Department of Child Health, St Michael's Hospital, University of Bristol, Bristol, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"2021120902465218700_R1","doi-asserted-by":"crossref","unstructured":"Agarwal G, Rastogi A, Pyati S, Wilks A, Pildes RS. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants \u22652500 g. J Perinatol.\u20082002;22(4):268\u2013274","DOI":"10.1038\/sj.jp.7210704"},{"key":"2021120902465218700_R2","doi-asserted-by":"crossref","unstructured":"Marti\u0301nez-Salgado C, Lopez-Hernandez FJ, Lopez-Novoa JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol.\u20082007;223(1):86\u201398","DOI":"10.1016\/j.taap.2007.05.004"},{"key":"2021120902465218700_R3","doi-asserted-by":"crossref","unstructured":"Rybak LP, Ramkumar V. Ototoxicity. Kidney Int.\u20082007;72(8):931\u2013935","DOI":"10.1038\/sj.ki.5002434"},{"key":"2021120902465218700_R4","doi-asserted-by":"crossref","unstructured":"Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet.\u20082004;19(3):159\u2013170","DOI":"10.2133\/dmpk.19.159"},{"key":"2021120902465218700_R5","doi-asserted-by":"crossref","unstructured":"Yow MD. An overview of pediatric experience with amikacin. Am J Med.\u20081977;62(6):954\u2013958","DOI":"10.1016\/0002-9343(77)90668-4"},{"key":"2021120902465218700_R6","doi-asserted-by":"crossref","unstructured":"Schentag JJ, Jusko WJ, Plaut ME, Cumbo TJ, Vance JW, Abrutyn E. Tissue persistence of gentamicin in man. JAMA.\u20081977;238(4):327\u2013329","DOI":"10.1001\/jama.238.4.327"},{"key":"2021120902465218700_R7","unstructured":"Rodriguez-Barbero A, Lopez-Novoa JM, Arevalo M. Involvement of platelet-activating factor in gentamicin nephrotoxicity in rats. Exp Nephrol.\u20081997;5(1):47\u201354"},{"key":"2021120902465218700_R8","doi-asserted-by":"crossref","unstructured":"Tran Ba Huy P, Meulemans A, Wassef M, Manuel C, Sterkers O, Amiel C. Gentamicin persistence in rat endolymph and perilymph after a two-day constant infusion. Antimicrob Agents Chemother.\u20081983;23(2):344\u2013346","DOI":"10.1128\/AAC.23.2.344"},{"key":"2021120902465218700_R9","doi-asserted-by":"crossref","unstructured":"Brion LP, Fleischman AR, Schwartz GJ. Gentamicin interval in newborn infants as determined by renal function and postconceptional age. Pediatr Nephrol.\u20081991;5(6):675\u2013679","DOI":"10.1007\/BF00857868"},{"key":"2021120902465218700_R10","doi-asserted-by":"crossref","unstructured":"Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM. Once- versus twice-daily gentamicin dosing in neonates \u226534 weeks' gestation: cost-effectiveness analyses. Pediatrics.\u20081999;103(3):594\u2013598","DOI":"10.1542\/peds.103.3.594"},{"key":"2021120902465218700_R11","unstructured":"Royal College of Paediatrics and Child Health, the Neonatal and Paediatric Pharmacists Group, the British Medical Association and the Royal Pharmaceutical Society of Great Britain. BNF for Children. London, United Kingdom: BMJ Publishing Group Ltd; 2006"},{"key":"2021120902465218700_R12","unstructured":"Pickering LK, ed. Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000:241\u2013242"},{"key":"2021120902465218700_R13","doi-asserted-by":"crossref","unstructured":"Smith CR, Lipsky JJ, Laskin OL, et al. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med.\u20081980;302(20):1106\u20131109","DOI":"10.1056\/NEJM198005153022002"},{"key":"2021120902465218700_R14","doi-asserted-by":"crossref","unstructured":"Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol.\u20082005;32(1):11\u201317","DOI":"10.1016\/j.pediatrneurol.2004.06.014"},{"key":"2021120902465218700_R15","doi-asserted-by":"crossref","unstructured":"Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet.\u20082005;365(9460):663\u2013670","DOI":"10.1016\/S0140-6736(05)70932-6"},{"key":"2021120902465218700_R16","doi-asserted-by":"crossref","unstructured":"Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med.\u20082005;353(15):1574\u20131584","DOI":"10.1056\/NEJMcps050929"},{"key":"2021120902465218700_R17","doi-asserted-by":"crossref","unstructured":"Hoehn T, Hansmann G, Bu\u0308hrer C, et al. Therapeutic hypothermia in neonates. Review of current clinical data, ILCOR recommendations and suggestions for implementation in neonatal intensive care units. Resuscitation.\u20082008;78(1):7\u201312","DOI":"10.1016\/j.resuscitation.2008.04.027"},{"key":"2021120902465218700_R18","doi-asserted-by":"crossref","unstructured":"Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med.\u20082007;35(9):2196\u20132204","DOI":"10.1097\/01.CCM.0000281517.97507.6E"},{"key":"2021120902465218700_R19","doi-asserted-by":"crossref","unstructured":"Guignard JP, Gillieron P. Effect of modest hypothermia on the immature kidney. Acta Paediatr.\u20081997;86(10):1040\u20131041","DOI":"10.1111\/j.1651-2227.1997.tb14802.x"},{"key":"2021120902465218700_R20","doi-asserted-by":"crossref","unstructured":"Thoresen M, Whitelaw A. Cardiovascular changes during mild therapeutic hypothermia and rewarming in infants with hypoxic-ischemic encephalopathy. Pediatrics.\u20082000;106(1 pt 1):92\u201399","DOI":"10.1542\/peds.106.1.92"},{"key":"2021120902465218700_R21","doi-asserted-by":"crossref","unstructured":"Ro\u0301ka A, Melinda KT, Vasarhelyi B, Machay T, Azzopardi D, Szabo M. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics.\u20082008;121(4). Available at: www.pediatrics.org\/cgi\/content\/full\/121\/4\/e844","DOI":"10.1542\/peds.2007-1987"},{"key":"2021120902465218700_R22","unstructured":"Thoresen MHN, Brun C. Hypothermia after perinatal asphyxia more than doubles the plasma half-life of phenobarbitone [abstract]. Pediatr Res.\u20082003;53(5):873"},{"key":"2021120902465218700_R23","doi-asserted-by":"crossref","unstructured":"Withington D, Menard G, Harris J, Kulkarni P, Donati F, Varin F. Vecuronium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. Can J Anaesth.\u20082000;47(12):1188\u20131195","DOI":"10.1007\/BF03019867"},{"key":"2021120902465218700_R24","doi-asserted-by":"crossref","unstructured":"DiCenzo R, Forrest A, Slish JC, Cole C, Guillet R. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy.\u20082003;23(5):585\u2013591","DOI":"10.1592\/phco.23.5.585.32196"},{"key":"2021120902465218700_R25","doi-asserted-by":"crossref","unstructured":"Kirkpatrick CM, Duffull SB, Begg EJ, Frampton C. The use of a change in gentamicin clearance as an early predictor of gentamicin-induced nephrotoxicity. Ther Drug Monit.\u20082003;25(5):623\u2013630","DOI":"10.1097\/00007691-200310000-00012"},{"key":"2021120902465218700_R26","unstructured":"Lorian V, ed. Antibiotics in Laboratory Medicine: Making a Difference. Philadelphia, PA: Lippincott Williams & Wilkins; 2005"},{"key":"2021120902465218700_R27","doi-asserted-by":"crossref","unstructured":"Auron A, Mhanna MJ. Serum creatinine in very low birth weight infants during their first days of life. J Perinatol.\u20082006;26(12):755\u2013760","DOI":"10.1038\/sj.jp.7211604"},{"key":"2021120902465218700_R28","unstructured":"Bertotti A, De Marchi S, Brovedani P, Gaeta G, Peratoner L, Mangiarotti MA. Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP). Pediatr Med Chir.\u20081990;12(4):347\u2013349"},{"key":"2021120902465218700_R29","doi-asserted-by":"crossref","unstructured":"Richardson GP, Russell IJ. Cochlear cultures as a model system for studying aminoglycoside induced ototoxicity. Hear Res.\u20081991;53(2):293\u2013311","DOI":"10.1016\/0378-5955(91)90062-E"},{"key":"2021120902465218700_R30","doi-asserted-by":"crossref","unstructured":"Tablan OC, Reyes MP, Rintelmann WF, Lerner AM. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis. J Infect Dis.\u20081984;149(2):257\u2013263","DOI":"10.1093\/infdis\/149.2.257"},{"key":"2021120902465218700_R31","doi-asserted-by":"crossref","unstructured":"Bitner-Glindzicz M, Rahman S. Ototoxicity caused by aminoglycosides. BMJ.\u20082007;335(7624):784\u2013785","DOI":"10.1136\/bmj.39301.680266.AE"},{"key":"2021120902465218700_R32","doi-asserted-by":"crossref","unstructured":"Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol.\u20082000;5(1):3\u201322","DOI":"10.1159\/000013861"},{"key":"2021120902465218700_R33","doi-asserted-by":"crossref","unstructured":"Satas S, Hoem NO, Melby K, et al. Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs. Biol Neonate.\u20082000;77(1):50\u201357","DOI":"10.1159\/000014195"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/1\/310\/1032290\/zpe00709000310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/124\/1\/310\/1032290\/zpe00709000310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T15:41:13Z","timestamp":1639064473000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/124\/1\/310\/71649\/Serum-Gentamicin-Concentrations-in-Encephalopathic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,7,1]]},"published-print":{"date-parts":[[2009,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2008-2942","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,1]]}}}